Kane Biotech Inc. (TSXV:KNE)

Kane Biotech Revenue

Kane Biotech had revenue of 8.50K CAD in the quarter ending September 30, 2025, a decrease of -99.34%. This brings the company's revenue in the last twelve months to 574.87K, down -71.44% year-over-year. In the year 2024, Kane Biotech had annual revenue of 2.08M with 1,296.75% growth.

• Revenue (ttm): 574.87K
• Revenue Growth: -71.44%
• P/S Ratio: 9.49
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 5.46M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.08M	1.93M	1,296.75%
Dec 31, 2023	148.98K	-7.75K	-4.95%
Dec 31, 2022	156.73K	-1.45M	-90.25%
Dec 31, 2021	1.61M	266.20K	19.84%
Dec 31, 2020	1.34M	-351.95K	-20.78%